As a nurse in the antidepressant 2.0 era, I'm teaching my patients to cut down their doses using jewelry scales

AI SUMMARY

# Investing Summary Outro, a telehealth platform enabling medically-supervised antidepressant tapering, addresses a significant market opportunity as demand grows for alternatives to long-term psychiatric medication management, potentially disrupting traditional psychiatry practices and creating competition for established pharmaceutical companies' patient retention. The company's focus on dose reduction using precision measurement tools targets the underserved antidepressant discontinuation market, which could capture market share from standard psychiatric care models while facing regulatory scrutiny around medication management protocols.